Identification of Lead Compounds as Inhibitors of STAT3: Design, Synthesis and Bioactivity

Mol Inform. 2015 Oct;34(10):689-97. doi: 10.1002/minf.201500043. Epub 2015 Jul 1.

Abstract

STAT3 belongs to the signal transducers and activators of transcription (STAT) family. It has been demonstrated that STAT3 is constitutively activated in many tumors, playing a role in carcinogenesis and tumor progression. For this reason, it has being considered a potential target for cancer therapy. In this context, we have designed, synthesized and evaluated 1,4-dimethyl-carbazole derivatives, targeting the STAT3 protein. Moreover, MTT assay performed on A375 and HeLa, showed significant antiproliferative activity of some of synthesized compounds (3-5). The same compounds (3-5) considerably reduced STAT3 expression, as demonstrated by Western blot analysis. Our multidisciplinary approach shows that 1,4-dimethyl-carbazoles are potential building blocks to develop more affinity ligands of STAT3.

Keywords: 1,4-dimethyl-carbazoles; Antitumor compound; Molecular docking; STAT3; STAT3 inhibitor.

MeSH terms

  • Antineoplastic Agents* / chemical synthesis
  • Antineoplastic Agents* / chemistry
  • Antineoplastic Agents* / pharmacology
  • Carbazoles* / chemical synthesis
  • Carbazoles* / chemistry
  • Carbazoles* / pharmacology
  • Cell Proliferation / drug effects*
  • HeLa Cells
  • Humans
  • Lead* / chemistry
  • Lead* / pharmacology
  • Neoplasm Proteins* / antagonists & inhibitors
  • Neoplasm Proteins* / chemistry
  • Neoplasm Proteins* / metabolism
  • Neoplasms* / chemistry
  • Neoplasms* / drug therapy
  • Neoplasms* / metabolism
  • STAT3 Transcription Factor* / antagonists & inhibitors
  • STAT3 Transcription Factor* / chemistry
  • STAT3 Transcription Factor* / metabolism

Substances

  • Antineoplastic Agents
  • Carbazoles
  • Neoplasm Proteins
  • STAT3 Transcription Factor
  • STAT3 protein, human
  • Lead